Novel insights into M3 muscarinic acetylcholine receptor physiology and structure.
Recent studies with M3 muscarinic acetylcholine receptor (M3R) mutant mice suggest that drugs selectively targeting this receptor subtype may prove useful for the treatment of various pathophysiological conditions. Moreover, the use of M3R-based designer G protein-coupled receptors (GPCRs) has provided novel insights into how Gq-coupled GPCRs can modulate whole-body glucose homeostasis by acting on specific peripheral cell types. More recently, we succeeded in using X-ray crystallography to determine the structure of the M3R bound to the bronchodilating drug tiotropium, a muscarinic antagonist (inverse agonist). This new structural information should facilitate the development of orthosteric or allosteric M3R-selective drugs that are predicted to have considerable therapeutic potential.
Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
Andrew C
AC
Kruse
Jianhua
J
Li
Jianxin
J
Hu
Brian K
BK
Kobilka
Jürgen
J
Wess
D000818:Animals; D001665:Binding Sites; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D011485:Protein Binding; D043587:Receptor, Muscarinic M3 / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*
D043587:Receptor, Muscarinic M3